Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Press release | 07 July 2026 MSF calls for inclusion of analogue insulin pens to the Kenyan Social Health Authority benefits package
Technical brief | 24 June 2026 The diagnostic blind spot in the 2026 Bundibugyo Ebola disease outbreak: access gaps and priority actions
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Letter | 28 February 2002 Intellectual property and trade Joint Letter to the TRIPS Council January 2002 7 min
Issue brief | 25 February 2002 Tropical & neglected diseases DNDi, the Drugs for Neglected Diseases Initiative: A global initiative to develop drugs for those in need 10 min
Events | 21 February 2002 Intellectual property and trade Implementation of the Doha Declaration on TRIPS and Public Health - Information
Press release | 13 February 2002 Malaria Number One Killer of Children in Africa Too Expensive to Treat Effectively?
Report | 12 February 2002 Research and development The Crisis of Neglected Diseases: Developing Treatments and Ensuring Access - Conference report 18 min
Letter | 06 February 2002 HIV/AIDS South Africa Letter to South African President Thabo Mbeki from Support Groups. Antiretroviral Programme, Khayelitsha
Newsletter | 01 February 2002 HIV/AIDS Intellectual property and trade Malaria Tropical & neglected diseases Vaccines Access News 6, Focus on Malaria, February 2002
Issue brief | 01 February 2002 Intellectual property and trade The TRIPS Agenda at the WTO after the Doha Declaration on Public Health 9 min
